Cartesian Therapeutics, Inc. RNAC
6.41 USD +0.07 (+1.10%)
At closeNov 3, 2026, 4:00 PM EST
6.41 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
6.37 Day range 6.68
5.60 52-week range 11.00
- YTD
- -11.10%
- 1 year
- -21.16%
Analyst view
Consensus: buy
Buy
Price target (mean) 38.17 +495.4% upside
Now 6.41
- Target (low)
- 22.00
- Target (mean)
- 38.17
- Target (high)
- 45.00
Ratings (0m) 8 6 buy · 2 hold · 0 sell
- Strong buy2
- Buy4
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 6
- 2 months ago 6
- 3 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 100.00K | -99.6% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 1.00M | -82.9% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 39.74M | +52.8% | 0 |
| Next year | -2.30 | -2.30 – -2.30 | 0.00 | 0.0% | 5.50M | -86.2% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 19, 2024 | BTIG | Initiated | — | Buy |
| Dec 4, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 3, 2024 | Needham | Reiterated | Buy | Buy |
| Nov 25, 2024 | Needham | Reiterated | Buy | Buy |
| Nov 8, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 8, 2024 | Needham | Reiterated | Buy | Buy |
| Oct 16, 2024 | Needham | Reiterated | Buy | Buy |
| Sep 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 4, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 12, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 9, 2024 | Needham | Maintained | Buy | Buy |
| Aug 6, 2024 | TD Cowen | Initiated | — | Buy |
| Jul 8, 2024 | Needham | Reiterated | Buy | Buy |
| Jul 3, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 3, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Jul 2, 2024 | Oppenheimer | Downgrade | Outperform | Peer Perform |
| Jul 1, 2024 | Needham | Reiterated | Buy | Buy |
| Jun 24, 2024 | Oppenheimer | Reiterated | Outperform | Outperform |
| Jun 17, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 14, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Jun 4, 2024 | Oppenheimer | Initiated | — | Outperform |
| May 24, 2024 | Mizuho | Initiated | — | Buy |
| May 23, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 9, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 8, 2024 | Needham | Reiterated | Buy | Buy |
| Apr 23, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 23, 2024 | Leerink Partners | Initiated | — | Outperform |
| Apr 10, 2024 | Needham | Reiterated | Buy | Buy |
| Apr 9, 2024 | Needham | Initiated | — | Buy |
| Mar 18, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |